ACAD
33.35
+1.39
+4.35%
AEMD
0.24
+0.03
+11.89%
APRI
1.92
+0.01
+0.52%
ARNA
4.48
+0.15
+3.46%
ATEC
1.41
+0.01
+0.71%
CNAT
7.53
-0.22
-2.84%
CRXM
0.195
0.00
0.00%
CYTX
1.2
+0.01
+0.84%
DXCM
61.98
+1.82
+3.03%
GNMK
13.3
+0.01
+0.08%
HALO
14
+0.07
+0.50%
ILMN
187.62
+0.45
+0.24%
INNV
0.179
+0.049
+37.5096%
INO
8.33
+0.05
+0.54%
ISCO
0.059
-0.003
-4.0984%
ISIS
64.81
+1.44
+2.27%
LGND
76.23
+3.28
+4.50%
LPTN
2.47
-0.01
-0.40%
MBVX
1.86
+0.24
+14.81%
MEIP
1.75
+0.01
+0.57%
MNOV
3.59
+0.04
+1.13%
MRTX
29.11
+0.69
+2.43%
MSTX
0.498
-0.002
-0.3006%
NBIX
41.53
+2.75
+7.09%
NUVA
46.4
+1.8
+4.04%
ONCS
0.35
0.00
0.00%
ONVO
3.37
-0.29
-7.92%
OREX
7.75
+0.21
+2.79%
OTIC
35.63
+1.4
+4.09%
QDEL
27.5
+0.35
+1.29%
RCPT
160.05
+12.62
+8.56%
RGLS
17.26
+0.44
+2.62%
RMD
71.65
+0.1
+0.14%
SCIE
0.026
-0.006
-17.7419%
SPHS
0.55
-0.04
-6.76%
SRNE
11.36
-0.93
-7.57%
TROV
7
0.00
0.00%
VICL
0.9
-0.02
-2.46%
VOLC
17.99
0.00
0.00%
ZGNX
1.37
+0.03
+2.24%
ACAD
33.35
+1.39
+4.35%
AEMD
0.24
+0.03
+11.89%
APRI
1.92
+0.01
+0.52%
ARNA
4.48
+0.15
+3.46%
ATEC
1.41
+0.01
+0.71%
CNAT
7.53
-0.22
-2.84%
CRXM
0.195
0.00
0.00%
CYTX
1.2
+0.01
+0.84%
DXCM
61.98
+1.82
+3.03%
GNMK
13.3
+0.01
+0.08%
HALO
14
+0.07
+0.50%
ILMN
187.62
+0.45
+0.24%
INNV
0.179
+0.049
+37.5096%
INO
8.33
+0.05
+0.54%
ISCO
0.059
-0.003
-4.0984%
ISIS
64.81
+1.44
+2.27%
LGND
76.23
+3.28
+4.50%
LPTN
2.47
-0.01
-0.40%
MBVX
1.86
+0.24
+14.81%
MEIP
1.75
+0.01
+0.57%
MNOV
3.59
+0.04
+1.13%
MRTX
29.11
+0.69
+2.43%
MSTX
0.498
-0.002
-0.3006%
NBIX
41.53
+2.75
+7.09%
NUVA
46.4
+1.8
+4.04%
ONCS
0.35
0.00
0.00%
ONVO
3.37
-0.29
-7.92%
OREX
7.75
+0.21
+2.79%
OTIC
35.63
+1.4
+4.09%
QDEL
27.5
+0.35
+1.29%
RCPT
160.05
+12.62
+8.56%
RGLS
17.26
+0.44
+2.62%
RMD
71.65
+0.1
+0.14%
SCIE
0.026
-0.006
-17.7419%
SPHS
0.55
-0.04
-6.76%
SRNE
11.36
-0.93
-7.57%
TROV
7
0.00
0.00%
VICL
0.9
-0.02
-2.46%
VOLC
17.99
0.00
0.00%
ZGNX
1.37
+0.03
+2.24%

Headline »

March 2, 2015 – 7:18 pm

In 2011 the San Diego Biotechnology Network (SDBN) hosted an event on “virtual” drug discovery, the then burgeoning idea that successful therapies could result from very small companies that rely on the internet-driven infrastructure to …

Read the full story »

Breaking San Diego Biotech News

Qualcomm Institute Launches Industry Innovation Space on UC San Diego Campus

March 30, 2015 – 1:19 pm

Working closely with other campus entities to translate ideas from the lab into products and companies in the marketplace, the Qualcomm Institute has launched an Innovation Space where qualified faculty startups, industry partners or national laboratories can lease office or lab space inside the research institute’s headquarters building on the University of California, San Diego campus.

Auspex bought for $3.2 billion

March 30, 2015 – 9:58 am

San Diego maker of “deuterated” drugs purchased by Israel’s Teva Pharma.

Teva Agrees to Buy San Diego’s Auspex Pharmaceuticals for $3B+

March 30, 2015 – 9:09 am

Israel’s Teva Pharmaceutical Industries (NYSE: TEVA) says today it has agreed to acquire San Diego-based Auspex Pharmaceuticals (NASDAQ: ASPX) in a cash deal valued between $3.2 billion and $3.5…

[[Click headline to continue reading.]]

Building Pathways: How a Native Oncologist Makes a Difference With Cancer Care, Prevention

March 30, 2015 – 8:02 am

SAN DIEGO, CA–(Marketwired – March 30, 2015) – Judith Kaur first began to think of herself as a healer at five years old.


See All News>>

Newest San Diego Biotech Jobs

Scientific Program Manager – Salk Institute for Biological Studies – E627

Position Description:
Incumbent will serve as project manager for preclinical and clinical research efforts including guidance, strategy and execution. Duties include but are not limited to: leadership of project team, supervision of technicians, managing pre-clinical strategies …

Manufacturing Technician – Synthetic Genomics, Inc. – La Jolla, CA

Apply best practices in the development and execution of projects. Previous tracking code:….
From Synthetic Genomics, Inc. – 24 Mar 2015 07:28:52 GMT
– View all La Jolla jobs

Program Manager, Product Development – Synthetic Genomics, Inc. – La Jolla, CA

4+ years of biotechnology or pharmaceutical industrial research experience. 3+ years of program management experience in a biotechnology or pharmaceutical…
From Synthetic Genomics, Inc. – 24 Mar 2015 07:28:50 GMT
– View all L…

Caring Massage Therapist (Rancho Bernardo)

Full and Part-time openings for Massage Therapists licensed with CAMTC.
We are looking for very talented and professional therapists to work in a growing Spa. You must be reliable and able to work evenings and weekends so that we can accommodate man […


See All Jobs>>

San Diego Biotech Blog Feed

Trilink: Liquid Biopsies Are Viewed as “Liquid Gold” for Diagnostics

Invasive Needles and Scalpels Seen as Passé Noninvasive Sampling Advocates Focusing on Circulating Tumor Cells (CTCs)  New Companies are Pursuing the Liquid Biopsy “Gold Rush” Biopsy Basics As defined in Wikipedia, a biopsy is ‘a medical test commonly performed by … Continue reading →... More...

Membrane Penetration: The Super Fins!

Hello! I am going to be writing some articles for a cool new aquatic news website called The Super Fins. Check out my first piece!  Meet the Notothenioid Fish: Antarctic Icefish Uses Antifreeze in Blood to Survive... More...

Ryon Graf: STEAM day at Muirlands Middle School

29 March 2015 About a week ago I had the honor and privilege to attend Muirlands Middle School’s STEAM career day as an invited speaker. The last time I set foot on the Muirlands campus I was a student. As I walked by the front gate I had the distinct recollection of the sound of... More...

Su Lab: What the heck is NGLY1 and why is Mark2Cure targeting it in the next campaign?

NGLY1 is the gene encoding for Peptide-N(4)-(N-acetyl-beta-glucosaminyl)asparagine amidase (PNGase) AKA N-glycanase 1. A deficiency in this enzyme can disrupt protein quality control mechanisms in the cell, which as we’ve seen in the BioGPS Gene-of-the-week on BAG6 is very important. Learn... More...